BridgeBio Pharma BBIO Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's common stock?
- BridgeBio Pharma (BBIO) reported common stock of 500M in Q1 2026.
- How has BridgeBio Pharma's common stock changed year-over-year?
- BridgeBio Pharma's common stock increased by 253707.1% year-over-year, from 197K to 500M.
- What is the long-term trend for BridgeBio Pharma's common stock?
- Over 5 years (2020 to 2025), BridgeBio Pharma's common stock has grown at a 425.3% compound annual growth rate (CAGR), from 125K to 500M.
- What does common stock mean?
- The nominal value of the shares held by common stockholders.
- How do you interpret common stock?
- Changes are typically minimal unless there is a significant stock split or a change in par value policy.
- How does common stock compare across companies?
- Standardized across all public companies; reflects the legal capital structure.